semaglutide risk of cancer Can obesity meds also reduce risk? A retrospective study 1.1M patients found GLP-1 drugs, especially semaglutide, Weight-loss drugs may lower cancer

Lately, GSK-3 has been identified as an alternative target for drug-mediated neuroprotective effects against excitotoxicity of ischemic stroke in animal models because GSK-3 is a multifaceted protein with a variety of neurophysiological and cellular effects

If youre tired of trying the same old methods without seeing any results, then it might be time to try something new: Lipo-B12 injections

Human Evidence: Dementia/Alzheimers Outcomes Observational & Emulated-Trial data (signal of benefit) Large real-world datasets now associate GLP-1 use with lower dementia risk compared with other antidiabetic drugs

ASCO 2016, 2016